Neuropsychological Intervention for a Seniors Mental Health Population With Mild Cognitive Impairment

Nova Scotia Health Authority1 site in 1 country40 target enrollmentDecember 5, 2011

ConditionsMild Cognitive Impairment

Overview

Phase: N/A
Intervention: Not specified
Conditions: Mild Cognitive Impairment
Sponsor: Nova Scotia Health Authority
Enrollment: 40
Locations: 1
Primary Endpoint: Change in everyday memory functioning
Status: Active, Not Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Registry

clinicaltrials.gov

Start Date

December 5, 2011

End Date

December 5, 2025

Last Updated

last year

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

Nova Scotia Health Authority

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Clinical diagnosis of Mild Cognitive Impairment

Exclusion Criteria

•Clinical diagnosis of dementia
•History of neurological conditions known to impair cognition
•History of alcohol or drug abuse
•History of chronic psychiatric illness
•Current symptoms of moderate to severe depression (Geriatric Depression Scale \>19) or anxiety (Beck Anxiety Inventory \>15)

Outcomes

Primary Outcomes

Change in everyday memory functioning

Time Frame: Measured at baseline and months 3, 5, 8

Rivermead Behavioural Memory Test (3rd Edition)

Secondary Outcomes

Change in memory perception(Measured at baseline and months 3, 5, 8)
Change on traditional memory testing(Measured at baseline and months 3, 5, 8)
Change in quality of life(Measured at baseline and months 3, 5, 8)
Change in mood (i.e., self-report symptoms of depression)(Measured at baseline and months 3, 5, 8)
Change in mood (i.e., self-report symptoms of anxiety)(Measured at baseline and months 3, 5, 8)
Feasibility(Measured at end of study)
Change in other psychiatric symptoms (informant-report)(Measured at baseline and months 3, 5, 8)
Change in caregiver burden(Measured at baseline and months 3, 5, 8)